Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma

Journal of Clinical Oncology

Volumn 19, Issue 5, 2001, Pages 1344-1349

  Robnett, T J ^a   Machtay, M ^a   Stevenson, J P ^a   Algazy, K M ^a   Hahn, S M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEURORADIOLOGY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RISK ASSESSMENT; RISK FACTOR; SEX; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0035281920     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.5.1344     Document Type: Article

References (29)

1. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
2. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial
3. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
4. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III non-small cell lung cancer
5. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer
6. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small cell lung cancer: A randomized study
7. ASCO: Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer
8. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the radiation therapy oncology group experience
9. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04
10. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients
11. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multi-modality treatment: Long-term follow-up and investigations of late neuropsychologic effects
12. Adenocarcinoma of the lung: Recent results from the veterans administration lung group
13. The necropsy findings in carcinoma of the bronchus
14. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials
15. The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group
16. The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group
17. The treatment of single brain metastasis from non-oat cell lung carcinoma: Surgery and radiation versus radiation therapy alone
18. Brain irradiation for metastatic disease of lung origin
19. High incidence of isolated brain metastases (CNSMets) following complete response (CR) in advanced non-small cell lung cancer (NSCLC): A new challenge
20. Preoperative chemotherapy and chemoradiotherapy based on hyperfractionated accelerated radiotherapy followed by surgery in locally advanced (LAD) inoperable NSCLC stages IIIA and IIIB: The value of PCI
21. A randomized trial of chemotherapy and radiotherapy for stage III non-small cell lung cancer
22. Cranial irradiation in cancer of the lung of all cell types
23. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group
24. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer
25. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer
26. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
27. Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)